Analysis of herpes-specific cell-mediated immunity in patients with facial palsy

Analysis of herpes-specific cell-mediated immunity in patients with facial palsy - herpes-specific cell-mediated immunity in facial palsy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012660

Enrollment

100

Registered

2014-01-06

Start date

2014-01-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial palsy (Bell&#39

Interventions

patients with facial palsy 6 months blood collection 20ml, total 4 times normal control (volunteer) 1 day blood collection 20ml

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with facial palsy normal controls without facial palsy

Exclusion criteria

Exclusion criteria: patients or volunteers under 20 years old patients or volunteers without their agreements

Design outcomes

Primary

Measure	Time frame
1)To identify HSV or VZV DNA in tear and saliva using PCR procedure. 2)To measure HSV and VZV-specific immunoglobulin in patients' blood. 3)To measure VZV-specific cell-mediated immunity in patients with facial palsy using ELISPOT.	—

Countries

Japan

Contacts

Public ContactShin-Ichi Haginomori

Osaka Medical College Otolaryngology

hagi@osaka-med.ac.jp072-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026